DING, Xiaoyan et al. Patients with uHCC and Child-Pugh B8/9 also benefit from a combination of antiangiogenic agents and PD-1 inhibitors: a multicenter real-world study. Acta Oncologica, [S. l.], v. 64, p. 607–615, 2025. DOI: 10.2340/1651-226X.2025.42652. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/42652. Acesso em: 13 may. 2026.